Full Text View
Tabular View
No Study Results Posted
Related Studies
Screening and Brief Advice to Reduce Teen Substance Use
This study is ongoing, but not recruiting participants.
First Received: January 3, 2008   Last Updated: February 23, 2009   History of Changes
Sponsors and Collaborators: Children's Hospital Boston
Cambridge Health Alliance
Concord Hospital
Fallon Clinic
Tufts Medical Center
University of Vermont
Information provided by: Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT00592956
  Purpose

The major goal of this project is to assess the efficacy of a screening/brief provider advice intervention within a network of primary care practices.

We hypothesize that:

  1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use as measured by the Timeline Followback4 method;
  2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use;
  3. Among 12-18 year old well care patients who are at risk for driving/riding while impaired (DRWI), the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing DRWI risk behavior as measured by a standardized scale.

Condition Intervention Phase
Substance-Related Disorders
Behavioral: Computerized CRAFFT screen and brief physician advice
Phase II

MedlinePlus related topics: Alcohol
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Single Group Assignment, Efficacy Study
Official Title: Screening and Brief Advice to Reduce Teen Substance Use

Further study details as provided by Children's Hospital Boston:

Primary Outcome Measures:
  • Percent days abstinent from substance use [ Time Frame: 90 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cessation of substance use [ Time Frame: 90 days ] [ Designated as safety issue: No ]
  • Initiation of substance use [ Time Frame: 90 days ] [ Designated as safety issue: No ]
  • Driving under the influence of substances or riding with a driving who has been using substance [ Time Frame: 90 days ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 2500
Study Start Date: September 2004
Estimated Study Completion Date: November 2009
Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: No Intervention
Control participants will receive "care as usual" from their provider.
2: Experimental
Participants who receive the intervention will complete the CRAFFT screen on the computer, and receive information and advice on the computer regarding health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Behavioral: Computerized CRAFFT screen and brief physician advice
Participants who receive the intervention will complete the CRAFFT screen on the computer, and receive information and advice on the computer regarding health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.

Detailed Description:

Primary medical care providers have a unique opportunity to screen adolescent patients for substance abuse, to provide early intervention for those who screen positive, and to provide positive reinforcement to those who screen negative. We have previously developed a brief substance abuse screening test, the CRAFFT, which is developmentally appropriate for adolescents, practical for use in busy primary care offices, and both valid and reliable among adolescent medical patients. We have also developed a computerized version of the CRAFFT screen, which delivers information about the health effects of substance use and advice to adolescents, and gives to providers the patient's CRAFFT score and suggested "talking points" about drug and alcohol use to discuss with the patient. We now plan to develop and test an intervention that can be widely applied by busy primary care providers, within the confines of the usual well care visit, to youth at all levels of substance involvement.

The goal of this project is to augment the screening/brief advice intervention with educational materials, and then to assess the efficacy of this approach within a network of primary care practices. The specific aims of the project are:

  1. To augment the existing computer screening program with adolescent and parent education materials.
  2. To produce a provider training protocol that is tailored to the needs of busy primary care clinicians.
  3. To test the effect of the comprehensive intervention (screening, brief physician advice, and adolescent/parent education) in a network of primary care settings.
  4. To assess the practicality, acceptability, and cost of the intervention.
  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients arriving for well care
  • All levels of substance use
  • Able to read and understand English

Exclusion Criteria:

  • Will not be available for the next 12 months to complete study assessments
  • Unstable medical condition
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00592956

Locations
United States, Massachusetts
Cambridge Health Alliance
Cambridge, Massachusetts, United States, 02139
Fallon Clinic
Worcester, Massachusetts, United States, 01605
Tufts-New England Medical Center
Boston, Massachusetts, United States, 02111
United States, New Hampshire
Capital Region Family Health Center
Concord, New Hampshire, United States, 03301
United States, Vermont
University of Vermont
Burlington, Vermont, United States, 05405
Sponsors and Collaborators
Children's Hospital Boston
Cambridge Health Alliance
Concord Hospital
Fallon Clinic
Tufts Medical Center
University of Vermont
Investigators
Principal Investigator: John R Knight, MD Children's Hospital Boston
  More Information

Additional Information:
Publications:
Responsible Party: Children's Hospital Boston ( John R. Knight, MD )
Study ID Numbers: R01 DA018848, R01 DA018848
Study First Received: January 3, 2008
Last Updated: February 23, 2009
ClinicalTrials.gov Identifier: NCT00592956     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
Alcohol abuse
Substance abuse
Substance related disorders

Study placed in the following topic categories:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Ethanol

Additional relevant MeSH terms:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on May 07, 2009